Results 61 to 70 of about 129,223 (217)

HIV Infection and Opioid Treatment Enable the Engraftment of Kaposi Sarcoma‐Like Tumors Into Immunocompetent Mice

Journal of Medical Virology, Volume 98, Issue 7, July 2026.
ABSTRACT The Kaposi Sarcoma herpesvirus (KSHV) causes Kaposi sarcoma (KS), primary effusion lymphoma, a lymphoproliferative disease (KSHV‐multicentric Castleman's disease), and a cytokine inflammatory syndrome (KICS). These diseases occur more frequently, though not exclusively, among people living with HIV or other types of immune dysregulation. While
Julian Naipauer, Ezequiel Lacunza, Anuj Ahuja, Santas Rosario, Carolina Alejandra Alvarez Canete, Martin C. Abba, Ethel Cesarman, Sundaram Ramakrishnan, Enrique Mesri, Sabita Roy, Umakant Sharma   +10 more
wiley   +1 more source

The Detection and Role of Human Endogenous Retrovirus K (HML-2) In Rheumatoid Arthritis [PDF]

, 2008
A thesis submitted in partial fulfilment of the requirements of the University of Wolverhampton for the degree of Doctor of PhilosophyHuman endogenous retroviruses are the remnants of ancient retroviral infections present within our genome.
Freimanis, Graham L.
core  

Anti-HIV therapy: pipeline approaches and future directions

, 2011
Human immunodeficiency virus (HIV), with about 30 million deaths and double infections (in developing countries), is an open challenge today for global scientists.
Lavkush Dwivedi, Mansi Shrivastava
core   +1 more source

Identification of phytoconstituents of Tragia involucrata leaf extracts and evaluate their correlation with anti-inflammatory & antioxidant properties.

, 2021
AimsThe present investigation was aimed at exploring the phytoconstituents using Gas Chromatography Mass Spectroscopy and to evaluate antioxidant and anti-inflammatory properties of the leaf extracts.Materials and methodsThe extracts were obtained ...
Dua, K, Chellappan, DK, Velu, V, Radhakrishnan, V, Malipeddi, H, Kumar, N, Mehta, M, Fuloria, S, Gupta, G, Banerjee, S   +9 more
core   +1 more source

Switching from a Non-Protease Inhibitor-Based Regimen to the Fixed Dose Combination of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Clinical Practice [Corrigendum]

Drug Design, Development and Therapy, 2022
Ranzenigo M, Gianotti N, Galli L, et al. Drug Des Devel Ther. 2022;16:1975–1982. Page 1975, Abstract, Results, line five, the text “the ongoing regimen was based on NNRTIs in 37 (35%) and on InSTIs in 69 (65%)” should read “the ...
Ranzenigo M, Gianotti N, Galli L, Poli A, Mastrangelo A, Bruzzesi E, Chiurlo M, Nozza S, Bossolasco S, Spagnuolo V, Mancusi D, Termini R, Carini E, Lazzarin A, Castagna A   +14 more
doaj  

Efeitos da administração diária da associação estavudina/nelfinavir sobre os fetos e placentas da rata albina Effects of daily administration of a stavudine/nelfinavir association on the fetuses and placentas of female albino rats

Revista Brasileira de Ginecologia e Obstetrícia, 2011
OBJETIVO: avaliar o efeito da administração da associação estavudina/nelfinavir durante toda a prenhez da rata, avaliando seu peso e dos conceptos, bem como o número de implantações, fetos, placentas, reabsorções e mortalidades materna e fetal.
Gisela Maria Vieira Rodrigues de Carvalho, Mary Uchiyama Nakamura, Ricardo Santos Simões, Eliana Maria Restum Antonio, Adriana Wagngner, Tereza Maria Pereira Fontes, Luiz Kulay Júnior   +6 more
doaj   +1 more source

Antiretroviral drug use by individuals living with HIV/AIDS and compliance with the Clinical Protocol and Therapy Guidelines

Einstein (São Paulo), 2020
Objective To describe antiretroviral treatment regimens prescribed and their compliance with the Clinical Protocol and Therapy Guidelines of the Ministry of Health for the management of HIV infection.
Lucas Eduardo Fedaracz Brojan, Leticia Mara Marca, Frederico Alves Dias, Yanna Dantas Rattmann   +3 more
doaj   +2 more sources

Indirect comparison of 48-week efficacy and safety of long-acting cabotegravir and rilpivirine maintenance every 8 weeks with daily oral standard of care antiretroviral therapy in participants with virologically suppressed HIV-1-infection

BMC Infectious Diseases, 2022
Background Efficacy and safety of long-acting cabotegravir (CAB) + rilpivirine (RPV) every 8 weeks (Q8W) versus daily oral standard of care (SoC) maintenance in treatment-experienced individuals with virologically suppressed human immunodeficiency virus ...
Vasiliki Chounta, Sonya J. Snedecor, Sterling Wu, Nicolas Van de Velde   +3 more
doaj   +1 more source

Lamivudine’s efficacy and safety in preventing mother-to-child transmission of hepatitis B: A meta-analysis

The Turkish Journal of Gastroenterology, 2019
Background/Aims: Mother-to-child transmission (MTCT) is a common transmission mode of hepatitis B virus (HBV). It has been shown that the infection may occur in some infants despite the use of immunoprophylaxis, and many studies have demonstrated the ...
Pooyan Khalighinejad, Seyed Moayed Alavian, Mohammad Gholami Fesharaki, Rozita Jalilianhasanpour   +3 more
doaj   +1 more source

Gene Therapy and Gene Editing in Type 1 Diabetes: CRISPR‐Based β‐Cell Replacement and Treg Immune Modulation Approaches

Diabetes, Obesity and Metabolism, Volume 28, Issue 7, Page 5476-5491, July 2026.
ABSTRACT Background Type 1 diabetes mellitus (T1DM) is a chronic autoimmune disease marked by the destruction of pancreatic β‐cells, resulting in lifelong dependence on exogenous insulin. Despite advances in insulin delivery and glucose monitoring technologies, patients remain at risk for acute and long‐term complications, underscoring the need for ...
Tzu‐Min Lin, Hui‐Fang Chang, Tzu‐Ching Lin, Cheng‐Han Lin, Yu‐Ling Sun, Chih‐Sheng Lin   +5 more
wiley   +1 more source